Influenza Virus Matrix Protein is the Major Driving Force in Virus Budding

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 2000 Nov 23

PMID 11090151

Citations 115

Authors

P Gomez-Puertas

C Albo

A Vivo

A Portela

Affiliations

Soon will be listed here.

Abstract

To get insights into the role played by each of the influenza A virus polypeptides in morphogenesis and virus particle assembly, the generation of virus-like particles (VLPs) has been examined in COS-1 cell cultures expressing, from recombinant plasmids, different combinations of the viral structural proteins. The presence of VLPs was examined biochemically, following centrifugation of the supernatants collected from transfected cells through sucrose cushions and immunoblotting, and by electron-microscopic analysis. It is demonstrated that the matrix (M1) protein is the only viral component which is essential for VLP formation and that the viral ribonucleoproteins are not required for virus particle formation. It is also shown that the M1 protein, when expressed alone, assembles into virus-like budding particles, which are released in the culture medium, and that the recombinant M1 protein accumulates intracellularly, forming tubular structures. All these results are discussed with regard to the roles played by the virus polypeptides during virus assembly.

Citing Articles

Raman signatures of type A and B influenza viruses: molecular origin of the "" inactivation mechanism mediated by micrometric silicon nitride powder.

Pezzotti G, Yasukochi Y, Ohgitani E, Nakashio M, Shin-Ya M, Adachi T RSC Chem Biol. 2025; 6(2):182-208.

PMID: 39850321 PMC: 11751685. DOI: 10.1039/d4cb00237g.

Assembly of respiratory syncytial virus matrix protein lattice and its coordination with fusion glycoprotein trimers.

Sibert B, Kim J, Yang J, Ke Z, Stobart C, Moore M Nat Commun. 2024; 15(1):5923.

PMID: 39004634 PMC: 11247094. DOI: 10.1038/s41467-024-50162-x.

Pseudotyping Improves the Yield of Functional SARS-CoV-2 Virus-like Particles (VLPs) as Tools for Vaccine and Therapeutic Development.

Zak A, Hoang T, Yee C, Rizvi S, Prabhu P, Wen F Int J Mol Sci. 2023; 24(19).

PMID: 37834067 PMC: 10572262. DOI: 10.3390/ijms241914622.

The ins and outs of membrane bending by intrinsically disordered proteins.

Yuan F, Lee C, Sangani A, Houser J, Wang L, Lafer E Sci Adv. 2023; 9(27):eadg3485.

PMID: 37418523 PMC: 10328403. DOI: 10.1126/sciadv.adg3485.

TRIM21 restricts influenza A virus replication by ubiquitination-dependent degradation of M1.

Lin L, Wang X, Chen Z, Deng T, Yan Y, Dong W PLoS Pathog. 2023; 19(6):e1011472.

PMID: 37343022 PMC: 10325077. DOI: 10.1371/journal.ppat.1011472.

References

Sha B, Luo M . Structure of a bifunctional membrane-RNA binding protein, influenza virus matrix protein M1. Nat Struct Biol. 1997; 4(3):239-44. DOI: 10.1038/nsb0397-239. View

Cathomen T, Naim H, Cattaneo R . Measles viruses with altered envelope protein cytoplasmic tails gain cell fusion competence. J Virol. 1998; 72(2):1224-34. PMC: 124600. DOI: 10.1128/JVI.72.2.1224-1234.1998. View

Jin H, Leser G, Lamb R . The influenza virus hemagglutinin cytoplasmic tail is not essential for virus assembly or infectivity. EMBO J. 1994; 13(22):5504-15. PMC: 395508. DOI: 10.1002/j.1460-2075.1994.tb06885.x. View

Justice P, Sun W, Li Y, Ye Z, Grigera P, Wagner R . Membrane vesiculation function and exocytosis of wild-type and mutant matrix proteins of vesicular stomatitis virus. J Virol. 1995; 69(5):3156-60. PMC: 189017. DOI: 10.1128/JVI.69.5.3156-3160.1995. View

Harris A, Sha B, Luo M . Structural similarities between influenza virus matrix protein M1 and human immunodeficiency virus matrix and capsid proteins: an evolutionary link between negative-stranded RNA viruses and retroviruses. J Gen Virol. 1999; 80 ( Pt 4):863-869. DOI: 10.1099/0022-1317-80-4-863. View

Watanabe K, Handa H, Mizumoto K, Nagata K . Mechanism for inhibition of influenza virus RNA polymerase activity by matrix protein. J Virol. 1996; 70(1):241-7. PMC: 189810. DOI: 10.1128/JVI.70.1.241-247.1996. View

Kretzschmar E, Bui M, Rose J . Membrane association of influenza virus matrix protein does not require specific hydrophobic domains or the viral glycoproteins. Virology. 1996; 220(1):37-45. DOI: 10.1006/viro.1996.0283. View

Piccone M, Fernandez-Sesma A, Palese P . Mutational analysis of the influenza virus vRNA promoter. Virus Res. 1993; 28(2):99-112. DOI: 10.1016/0168-1702(93)90129-b. View

Lenard J . Negative-strand virus M and retrovirus MA proteins: all in a family?. Virology. 1996; 216(2):289-98. DOI: 10.1006/viro.1996.0064. View

10.

de la Luna S, Martinez C, Ortin J . Molecular cloning and sequencing of influenza virus A/Victoria/3/75 polymerase genes: sequence evolution and prediction of possible functional domains. Virus Res. 1989; 13(2):143-55. DOI: 10.1016/0168-1702(89)90012-9. View

11.

Rolls M, Webster P, Balba N, Rose J . Novel infectious particles generated by expression of the vesicular stomatitis virus glycoprotein from a self-replicating RNA. Cell. 1994; 79(3):497-506. DOI: 10.1016/0092-8674(94)90258-5. View

12.

Mitnaul L, Castrucci M, Murti K, Kawaoka Y . The cytoplasmic tail of influenza A virus neuraminidase (NA) affects NA incorporation into virions, virion morphology, and virulence in mice but is not essential for virus replication. J Virol. 1996; 70(2):873-9. PMC: 189890. DOI: 10.1128/JVI.70.2.873-879.1996. View

13.

Mebatsion T, Weiland F, Conzelmann K . Matrix protein of rabies virus is responsible for the assembly and budding of bullet-shaped particles and interacts with the transmembrane spike glycoprotein G. J Virol. 1998; 73(1):242-50. PMC: 103828. DOI: 10.1128/JVI.73.1.242-250.1999. View

14.

Vennema H, Godeke G, Rossen J, Voorhout W, Horzinek M, Opstelten D . Nucleocapsid-independent assembly of coronavirus-like particles by co-expression of viral envelope protein genes. EMBO J. 1996; 15(8):2020-8. PMC: 450121. View

15.

Mena I, Castillo M, Vivo A, Portela A . Efficient formation of influenza virus-like particles: dependence on the expression levels of viral proteins. J Gen Virol. 1999; 80 ( Pt 7):1635-1645. DOI: 10.1099/0022-1317-80-7-1635. View

16.

Lopez J, Guillen M, Sanchez-Fauquier A, Melero J . An antigen-binding assay to determine the specificity of monoclonal antibodies against influenza virus and mapping of epitopes. J Virol Methods. 1986; 13(3):255-64. DOI: 10.1016/0166-0934(86)90019-4. View

17.

Li Y, Luo L, Schubert M, Wagner R, Kang C . Viral liposomes released from insect cells infected with recombinant baculovirus expressing the matrix protein of vesicular stomatitis virus. J Virol. 1993; 67(7):4415-20. PMC: 237817. DOI: 10.1128/JVI.67.7.4415-4420.1993. View

18.

Palese P, Tobita K, Ueda M, Compans R . Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology. 1974; 61(2):397-410. DOI: 10.1016/0042-6822(74)90276-1. View

19.

Roberts A, Buonocore L, Price R, Forman J, Rose J . Attenuated vesicular stomatitis viruses as vaccine vectors. J Virol. 1999; 73(5):3723-32. PMC: 104148. DOI: 10.1128/JVI.73.5.3723-3732.1999. View

20.

Zvonarjev A, Ghendon Y . Influence of membrane (M) protein on influenza A virus virion transcriptase activity in vitro and its susceptibility to rimantadine. J Virol. 1980; 33(2):583-6. PMC: 288582. DOI: 10.1128/JVI.33.2.583-586.1980. View